JP2000511175A5 - - Google Patents

Download PDF

Info

Publication number
JP2000511175A5
JP2000511175A5 JP1997542377A JP54237797A JP2000511175A5 JP 2000511175 A5 JP2000511175 A5 JP 2000511175A5 JP 1997542377 A JP1997542377 A JP 1997542377A JP 54237797 A JP54237797 A JP 54237797A JP 2000511175 A5 JP2000511175 A5 JP 2000511175A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
JP1997542377A
Other languages
English (en)
Japanese (ja)
Other versions
JP2000511175A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US1997/006801 external-priority patent/WO1997044315A1/en
Publication of JP2000511175A publication Critical patent/JP2000511175A/ja
Publication of JP2000511175A5 publication Critical patent/JP2000511175A5/ja
Abandoned legal-status Critical Current

Links

JP09542377A 1996-05-17 1997-04-24 ビフェニルスルホンアミドマトリックスメタロプロテイナーゼ阻害剤 Abandoned JP2000511175A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US1746096P 1996-05-17 1996-05-17
US60/017,460 1996-05-17
PCT/US1997/006801 WO1997044315A1 (en) 1996-05-17 1997-04-24 Biphenylsulfonamide matrix metalloproteinase inhibitors

Publications (2)

Publication Number Publication Date
JP2000511175A JP2000511175A (ja) 2000-08-29
JP2000511175A5 true JP2000511175A5 (enExample) 2005-01-13

Family

ID=21782716

Family Applications (1)

Application Number Title Priority Date Filing Date
JP09542377A Abandoned JP2000511175A (ja) 1996-05-17 1997-04-24 ビフェニルスルホンアミドマトリックスメタロプロテイナーゼ阻害剤

Country Status (22)

Country Link
EP (1) EP0901466B1 (enExample)
JP (1) JP2000511175A (enExample)
KR (1) KR20000011095A (enExample)
CN (1) CN1077885C (enExample)
AT (1) ATE207891T1 (enExample)
BG (1) BG63940B1 (enExample)
BR (1) BR9710841A (enExample)
CA (1) CA2253342A1 (enExample)
CZ (1) CZ294063B6 (enExample)
DE (1) DE69707865T2 (enExample)
DK (1) DK0901466T3 (enExample)
EA (1) EA001561B1 (enExample)
EE (1) EE03965B1 (enExample)
ES (1) ES2167733T3 (enExample)
IL (1) IL126832A0 (enExample)
NO (1) NO312510B1 (enExample)
NZ (1) NZ332711A (enExample)
PL (1) PL186416B1 (enExample)
PT (1) PT901466E (enExample)
SK (1) SK282863B6 (enExample)
WO (1) WO1997044315A1 (enExample)
ZA (1) ZA974223B (enExample)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2193691A1 (en) * 1994-06-22 1995-12-28 Andrew Miller Metalloproteinase inhibitors
US6124333A (en) * 1995-06-22 2000-09-26 British Biotech Pharmaceuticals Limited Metalloproteinase inhibitors
KR20000057444A (ko) * 1996-12-09 2000-09-15 로즈 암스트롱, 크리스틴 에이. 트러트웨인 심기능부전 및 심실확장의 치료 및 예방 방법
SI0946166T1 (en) * 1996-12-17 2004-06-30 Warner-Lambert Company Llc Use of matrix metalloproteinase inhibitors for promoting wound healing
ES2212142T3 (es) 1996-12-17 2004-07-16 Warner-Lambert Company Llc Uso de inhibidores de metaloproteinasas de la matriz para promover la curacion de heridas.
GB9706255D0 (en) * 1997-03-26 1997-05-14 Smithkline Beecham Plc Novel compounds
DE19719621A1 (de) * 1997-05-09 1998-11-12 Hoechst Ag Sulfonylaminocarbonsäuren
JP3621427B2 (ja) * 1997-07-22 2005-02-16 塩野義製薬株式会社 糸球体障害治療または予防剤
EP1047450B1 (en) * 1997-12-23 2002-10-02 Warner-Lambert Company Ace inhibitor-mmp inhibitor combinations
JP4750272B2 (ja) * 1998-02-04 2011-08-17 ノバルティス アーゲー マトリックス分解メタロプロテイナーゼを阻害するスルホニルアミノ誘導体
US6410580B1 (en) 1998-02-04 2002-06-25 Novartis Ag Sulfonylamino derivatives which inhibit matrix-degrading metalloproteinases
EP1063991A1 (en) * 1998-03-17 2001-01-03 Warner-Lambert Company Llc Statin-matrix metalloproteinase inhibitor combinations
EP0967201A1 (en) * 1998-05-20 1999-12-29 Roche Diagnostics GmbH Pharmaceutical agents containing sulfonamids as matrix metalloproteinase inhibitors
AU754050B2 (en) 1998-07-16 2002-10-31 Sanofi-Aventis Deutschland Gmbh Phosphinous and phosphonic acid derivatives used as medicaments
CN1310629A (zh) * 1998-07-21 2001-08-29 沃尼尔·朗伯公司 用于治疗动脉粥样硬化损伤的acat和mmp抑制剂的合并给药
DE19851184A1 (de) * 1998-11-06 2000-05-11 Aventis Pharma Gmbh N-Arylsulfonyl-aminosäure-omega-amide
US6858598B1 (en) 1998-12-23 2005-02-22 G. D. Searle & Co. Method of using a matrix metalloproteinase inhibitor and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
AU765203B2 (en) * 1999-04-19 2003-09-11 Shionogi & Co., Ltd. Sulfonamide derivatives having oxadiazole rings
GB9918684D0 (en) 1999-08-09 1999-10-13 Novartis Ag Organic compounds
SI1249233T1 (sl) 1999-11-26 2009-02-28 Shionogi & Co Antagonisti NPYY5
CA2423885A1 (en) * 2000-09-29 2003-03-27 Shionogi & Co., Ltd. Thiazole and oxazole derivatives
GB0103303D0 (en) 2001-02-09 2001-03-28 Novartis Ag Organic compounds
MXPA01013326A (es) 2001-02-14 2002-08-26 Warner Lambert Co Bifenil sulfonamidas utiles como inhibisdores de metaloproteinasa de matriz.
WO2003035610A1 (en) * 2001-10-26 2003-05-01 Shionogi & Co., Ltd. Sulfonamide derivative having mmp inhibitory activity
GB0314488D0 (en) * 2003-06-20 2003-07-23 Glaxo Group Ltd Therapeutically useful compounds
CA2548513A1 (en) * 2003-12-04 2005-07-07 Wyeth Biaryl sulfonamides and methods for using same
WO2005092844A1 (en) 2004-03-22 2005-10-06 Southern Research Institute Nonpeptide inhibitors of matrix metalloproteinases
CN101279956B (zh) * 2008-04-25 2011-06-15 南昌大学 一种基质金属蛋白酶抑制剂及合成方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5506242A (en) * 1993-01-06 1996-04-09 Ciba-Geigy Corporation Arylsufonamido-substituted hydroxamic acids
CA2193691A1 (en) * 1994-06-22 1995-12-28 Andrew Miller Metalloproteinase inhibitors

Similar Documents

Publication Publication Date Title
JP2000502280A5 (enExample)
JP2000511435A5 (enExample)
JP2000510825A5 (enExample)
JP2000501771A5 (enExample)
JP2000501599A5 (enExample)
JP2000513721A5 (enExample)
JP2000501324A5 (enExample)
JP2000502472A5 (enExample)
JP2000501825A5 (enExample)
JP2000501338A5 (enExample)
JP2000502425A5 (enExample)
JP2000502485A5 (enExample)
JP2000502568A5 (enExample)
JP2000501774A5 (enExample)
JP2000502570A5 (enExample)
JP2000501876A5 (enExample)
JP2002515868A5 (enExample)
JP2000516211A5 (enExample)
JP2000501744A5 (enExample)
JP2000504462A5 (enExample)
JP2000501229A5 (enExample)
JP2000502316A5 (enExample)
JP2000511175A5 (enExample)
JP2001502673A5 (enExample)
JP2000502714A5 (enExample)